Treatment of Older Parkinson's Disease
- PMID: 28554416
- DOI: 10.1016/bs.irn.2017.01.005
Treatment of Older Parkinson's Disease
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease. The prevalence of PD increases with age. The spectrum of clinical features, the rate of progression of the disease, the burden of nonmotor symptoms, and the response to medications are different in older patients with PD from the relatively younger patients. Management of symptoms of PD in older patients is challenging because of possible existence of several age-related systemic illness. While dealing with older patients, it is crucial not to attribute all the physical symptoms to PD. Thorough evaluation for existence of diseases such as normal pressure hydrocephalus and vascular parkinsonism which partially mimic the symptoms of PD carries immense importance. Medical management of parkinsonian symptoms should be preferred with levodopa monotherapy. However, in patients with significant motor fluctuations, dopaminergic agents may be added with caution, as they are notorious for several adverse reactions. Nonmotor symptoms must be provided high importance as they substantially worsen the quality of life. In addition to parkinsonian symptoms, older patients with PD may need to undergo surgery for several conditions. Meticulous perioperative management is crucial as older patients with PD may face several surgery-related complications compared to the younger patients. Compliance to treatment is an important issue in old age. Hence multidisciplinary approach to management of PD in older patients should be emphasized.
Keywords: Geriatrics; Old age; Older Parkinson's disease; Parkinson's disease.
© 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Nonmotor Effects of Conventional and Transdermal Dopaminergic Therapies in Parkinson's Disease.Int Rev Neurobiol. 2017;134:989-1018. doi: 10.1016/bs.irn.2017.05.008. Epub 2017 Jun 12. Int Rev Neurobiol. 2017. PMID: 28805592 Review.
-
Evidence-based initiation of dopaminergic therapy in Parkinson's disease.J Neurol. 2010 Nov;257(Suppl 2):S309-13. doi: 10.1007/s00415-010-5718-x. J Neurol. 2010. PMID: 21080195 Review.
-
Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease.Am J Geriatr Pharmacother. 2010 Aug;8(4):294-315. doi: 10.1016/j.amjopharm.2010.08.002. Am J Geriatr Pharmacother. 2010. PMID: 20869620 Review.
-
Osteoporosis: A Hidden Nonmotor Face of Parkinson's Disease.Int Rev Neurobiol. 2017;134:877-890. doi: 10.1016/bs.irn.2017.05.034. Epub 2017 Jul 10. Int Rev Neurobiol. 2017. PMID: 28805587 Review.
-
New treatments for the motor symptoms of Parkinson's disease.Expert Rev Clin Pharmacol. 2014 Nov;7(6):761-77. doi: 10.1586/17512433.2014.966812. Expert Rev Clin Pharmacol. 2014. PMID: 25318835 Review.
Cited by
-
Parkinson's disease prevalence, age distribution and staging in Colombia.Neurol Int. 2020 Jul 10;12(1):8401. doi: 10.4081/ni.2020.8401. eCollection 2020 Jul 10. Neurol Int. 2020. PMID: 32774822 Free PMC article.
-
Overexpression of MicroRNA-133a Inhibits Apoptosis and Autophagy in a Cell Model of Parkinson's Disease by Downregulating Ras-Related C3 Botulinum Toxin Substrate 1 (RAC1).Med Sci Monit. 2020 Jul 27;26:e922032. doi: 10.12659/MSM.922032. Med Sci Monit. 2020. Retraction in: Med Sci Monit. 2022 Oct 26;28:e938747. doi: 10.12659/MSM.938747. PMID: 32713934 Free PMC article. Retracted.
-
Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson's Disease?Int J Mol Sci. 2021 Mar 16;22(6):3038. doi: 10.3390/ijms22063038. Int J Mol Sci. 2021. PMID: 33809767 Free PMC article. Review.
-
Parkinson's Disease in the Era of Personalised Medicine: One Size Does Not Fit All.Drugs Aging. 2019 Feb;36(2):103-113. doi: 10.1007/s40266-018-0624-5. Drugs Aging. 2019. PMID: 30556112
-
Higher Serum Galectin‑3 Levels Were Associated with More Severe Motor Performance in Parkinson's Disease.J Inflamm Res. 2024 Nov 4;17:8207-8214. doi: 10.2147/JIR.S491557. eCollection 2024. J Inflamm Res. 2024. PMID: 39525309 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical